论文信息 - Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants. - 字舞流文

Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants.

T. Kato | A. Tzakis | G. Ciancio | G. Burke | Joshua Miller | V. Esquenazi | Tomoaki Kato | J. Mathew | J. Mathew | D. Weppler | J. Miller | M. Carreño | L. Fuller | R. Garcia-Morales | C. Gomez | Carmen Gomez | F. Salman | G. Burke | Frank Salman

[1] T. Taniguchi,et al. The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[2] N. Tanaka,et al. Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[3] T. Waldmann,et al. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. , 1991, Transplantation.

[4] T. Waldmann. The multi-subunit interleukin-2 receptor. , 1989, Annual review of biochemistry.

[5] B. Cullen,et al. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. , 1986, Science.

[6] T. Waldmann,et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.

[7] T. Waldmann,et al. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.